Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus – defining adequate administration methods

Type 2 diabetes mellitus accounts for 90%-95% of all cases of diabetes mellitus and is caused due to insulin deficiency superimposed on insulin resistance. The former is the major defect resulting in a blunted response of pancreatic beta cells to secrete Insulin in response to increased blood glucose levels.